Raffles Medical Group Ltd
SGX:BSL
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.86
1.09
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SGD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Raffles Medical Group Ltd
Raffles Medical Group Ltd
Cost of Revenue
Raffles Medical Group Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Raffles Medical Group Ltd
SGX:BSL
|
Cost of Revenue
-S$45.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
16%
|
CAGR 10-Years
4%
|
|
|
I
|
ISEC Healthcare Ltd
SGX:40T
|
Cost of Revenue
-S$39.5m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-17%
|
|
|
O
|
Oue Lippo Healthcare Ltd
SGX:5WA
|
Cost of Revenue
-S$36.6m
|
CAGR 3-Years
-100%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
-7%
|
|
|
A
|
Asia Vets Holdings Ltd
SGX:5RE
|
Cost of Revenue
-S$1.8m
|
CAGR 3-Years
8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
24%
|
|
|
Thomson Medical Group Ltd
SGX:A50
|
Cost of Revenue
-S$75.2m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Raffles Medical Group Ltd
Glance View
Raffles Medical Group Ltd. is an investment holding company, which engages in the operation of medical clinics and other general medical services. The firm is focused on providing a range of services from primary and tertiary care to health insurance for people across Asia. The firm operates approximately 100 multi-disciplinary clinics in 14 cities in Singapore, China, Japan, Vietnam and Cambodia. The firm's integrated healthcare organization consists of a tertiary hospital, a network of family medicine and dental clinics, insurance services, Japanese and Traditional Chinese medicine clinics, and a consumer healthcare division. Its healthcare division develops and distributes a range of nutraceuticals, supplements, vitamins and medical diagnostic equipment for personal healthcare in Singapore and in the regional markets. The Company’s subsidiaries include Raffles Medical, Raffles Hospital, Raffles Dental, Raffles Chinese Medicine, Raffles Health Insurance, Raffles Healthcare Institute and Raffles Health.
See Also
What is Raffles Medical Group Ltd's Cost of Revenue?
Cost of Revenue
-45.7m
SGD
Based on the financial report for Jun 30, 2024, Raffles Medical Group Ltd's Cost of Revenue amounts to -45.7m SGD.
What is Raffles Medical Group Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
4%
Over the last year, the Cost of Revenue growth was 23%. The average annual Cost of Revenue growth rates for Raffles Medical Group Ltd have been 32% over the past three years , 16% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
